Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 5NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1CNS 1

Conditions

Breast Neoplasms 6Breast Neoplasms, Male 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Uterine Cervical Neoplasms 1Teratoma 1Seminoma 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neurofibrosarcoma 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1Hematologic Neoplasms 1Endodermal Sinus Tumor 1Central Nervous System Neoplasms 1Carcinoma, Embryonal 1

Interventions

Radiotherapy 30Temozolomide 16Carboplatin 16Chemotherapy, Adjuvant 15Cisplatin 13Vincristine 12Magnetic Resonance Spectroscopy 12Cyclophosphamide 11Etoposide 10Carmustine 10Methotrexate 8Specimen Handling 7Peripheral Blood Stem Cell Transplantation 7Filgrastim 7X-Rays 6Thiotepa 6Surgical Procedures, Operative 6Phantoms, Imaging 6O(6)-benzylguanine 6Lomustine 6Biopsy 6motexafin gadolinium 4Nuclear Medicine Department, Hospital 4Drug Therapy 4Tamoxifen 3Psychiatric Rehabilitation 3Procarbazine 3Neoadjuvant Therapy 3Mental Status and Dementia Tests 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Central Nervous System Neoplasms × pegfilgrastim × Clear all
NCT01172912 2013-08-12

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy

National Cancer Institute (NCI)

Phase 2 Unknown
47 enrolled
CNSGenitourinary

Testicular Germ Cell Tumor, Testicular Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡